Orlistat induces apoptosis and protective autophagy in ovarian cancer cells: involvement of Akt-mTOR-mediated signaling pathway
Authors:
- 4 July 2018
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 298 (3) , 597-605
Abstract
Orlistat possesses anti-tumor capacity by inducing apoptosis in ovarian cancer cells. However, the mechanism is not clearly understood. Emerging evidence indicates the overlaps between autophagy and apoptosis. In this study, we have investigated the role of autophagy in orlistat-induced apoptosis in ovarian cancer (OC) cells.Keywords
Funding Information
- Key Research and Development Program of Sichuan Province (2017SZ0002)
This publication has 30 references indexed in Scilit:
- Inhibition of Fatty Acid Synthase Attenuates CD44-Associated Signaling and Reduces Metastasis in Colorectal CancerCancer Research, 2012
- Ovarian Cancer Risk Associated with Inherited Inflammation-Related VariantsCancer Research, 2012
- Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver functionProceedings of the National Academy of Sciences, 2012
- A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell linesBreast Cancer Research, 2011
- The multiple roles of autophagy in cancerCarcinogenesis, 2011
- Autophagy fights disease through cellular self-digestionNature, 2008
- Apoptosis and autophagy: regulatory connections between two supposedly different processesApoptosis, 2007
- The role of autophagy in cancer development and response to therapyNature Reviews Cancer, 2005
- Cell DeathCell, 2004
- The Hallmarks of CancerCell, 2000